| Emerging role of PTEN loss in evasion of the immune response to tumours T Vidotto, CM Melo, E Castelli, M Koti, RB Dos Reis, JA Squire British journal of cancer 122 (12), 1732-1743, 2020 | 147 | 2020 |
| DNA damage repair gene mutations and their association with tumor immune regulatory gene expression in muscle invasive bladder cancer subtypes T Vidotto, S Nersesian, C Graham, DR Siemens, M Koti Journal for immunotherapy of cancer 7, 1-12, 2019 | 84 | 2019 |
| PTEN‐deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells T Vidotto, FP Saggioro, T Jamaspishvili, DL Chesca, ... The Prostate 79 (9), 969-979, 2019 | 83 | 2019 |
| Plasma cells are enriched in localized prostate cancer in Black men and are associated with improved outcomes AB Weiner, T Vidotto, Y Liu, AA Mendes, DC Salles, FA Faisal, S Murali, ... Nature communications 12 (1), 935, 2021 | 82 | 2021 |
| GPNMB expression identifies TSC1/2/mTOR‐associated and MiT family translocation‐driven renal neoplasms DC Salles, K Asrani, J Woo, T Vidotto, HB Liu, I Vidal, A Matoso, GJ Netto, ... The Journal of Pathology 257 (2), 158-171, 2022 | 45 | 2022 |
| Serotonin synthesis protects the mouse colonic crypt from DNA damage and colorectal tumorigenesis JY Sakita, M Bader, ES Santos, SB Garcia, SB Minto, N Alenina, ... The Journal of pathology 249 (1), 102-113, 2019 | 41 | 2019 |
| In prostate cancer needle biopsies, detections of PTEN loss by fluorescence in situ hybridization (FISH) and by immunohistochemistry (IHC) are concordant and show consistent … CG Picanço-Albuquerque, CL Morais, FLF Carvalho, SB Peskoe, JL Hicks, ... Virchows Archiv 468, 607-617, 2016 | 41 | 2016 |
| Increased STAT1 expression in high grade serous ovarian cancer is associated with a better outcome JA Josahkian, FP Saggioro, T Vidotto, HT Ventura, FJC Dos Reis, ... International Journal of Gynecologic Cancer 28 (3), 2018 | 31 | 2018 |
| Risk stratification of prostate cancer through quantitative assessment of PTEN loss (qPTEN) T Jamaspishvili, PG Patel, Y Niu, T Vidotto, I Caven, R Livergant, W Fu, ... JNCI: Journal of the National Cancer Institute 112 (11), 1098-1104, 2020 | 28 | 2020 |
| CDKN1B Deletions are Associated with Metastasis in African American Men with Clinically Localized, Surgically Treated Prostate Cancer FA Faisal, S Murali, H Kaur, T Vidotto, LB Guedes, DC Salles, V Kothari, ... Clinical Cancer Research 26 (11), 2595-2602, 2020 | 28 | 2020 |
| Distinct subtypes of genomic PTEN deletion size influence the landscape of aneuploidy and outcome in prostate cancer T Vidotto, DG Tiezzi, JA Squire Molecular Cytogenetics 11, 1-12, 2018 | 28 | 2018 |
| Pan-cancer genomic analysis shows hemizygous PTEN loss tumors are associated with immune evasion and poor outcome T Vidotto, CM Melo, W Lautert-Dutra, LP Chaves, RB Reis, JA Squire Scientific Reports 13 (1), 5049, 2023 | 24 | 2023 |
| Reciprocal YAP1 loss and INSM1 expression in neuroendocrine prostate cancer K Asrani, AFC Torres, J Woo, T Vidotto, HK Tsai, J Luo, E Corey, ... The Journal of pathology 255 (4), 425-437, 2021 | 24 | 2021 |
| Sexual dimorphism in outcomes of non–muscle-invasive bladder cancer: a role of CD163+ macrophages, B cells, and PD-L1 immune checkpoint S Chenard, C Jackson, T Vidotto, L Chen, C Hardy, T Jamaspishvilli, ... European Urology Open Science 29, 50-58, 2021 | 21 | 2021 |
| An mTORC1-mediated negative feedback loop constrains amino acid-induced FLCN-Rag activation in renal cells with TSC2 loss K Asrani, J Woo, AA Mendes, E Schaffer, T Vidotto, CR Villanueva, ... Nature communications 13 (1), 6808, 2022 | 20 | 2022 |
| Transcriptional landscape of PTEN loss in primary prostate cancer EL Imada, DF Sanchez, W Dinalankara, T Vidotto, EM Ebot, ... BMC cancer 21, 1-13, 2021 | 20 | 2021 |
| Association between pathogenic germline mutations in BRCA2 and ATM and tumor-infiltrating lymphocytes in primary prostate cancer HB Kaur, T Vidotto, AA Mendes, DC Salles, WB Isaacs, ES Antonarakis, ... Cancer Immunology, Immunotherapy, 1-9, 2022 | 18 | 2022 |
| High throughput assessment of biomarkers in tissue microarrays using artificial intelligence: PTEN loss as a proof-of-principle in multi-center prostate cancer cohorts SA Harmon, PG Patel, TH Sanford, I Caven, R Iseman, T Vidotto, ... Modern Pathology 34 (2), 478-489, 2021 | 18 | 2021 |
| Investigating the STING pathway to explain mechanisms of BCG failures in non-muscle invasive bladder cancer: prognostic and therapeutic implications M Koti, S Chenard, S Nersesian, T Vidotto, A Morales, DR Siemens Bladder Cancer 5 (3), 225-234, 2019 | 9 | 2019 |
| PTEN loss in Gleason grade 7 prostate tumors exhibits intratumoral heterogeneity and is associated with unfavorable pathological features CG Picanço-Albuquerque, T Vidotto, CS Pereira, FP Saggioro, ... Applied Cancer Research 39, 1-6, 2019 | 7 | 2019 |
Jeremy SquireDepartmento de Genética, Faculdade de Medicina de Ribeirão Preto, University of Sao PauloVerified email at fmrp.usp.br
